Meghan M. Morrison
YOU?
Author Swipe
View article: Considerations for the Use of Commercial Wearables to Assess Sleep and Rest-Activity Rhythms
Considerations for the Use of Commercial Wearables to Assess Sleep and Rest-Activity Rhythms Open
Use of wearables, which can be considered as devices worn on the body that capture dimensions of health, are common in research. Wearables are useful as they can be employed in a number of environments for a variety of populations and can …
View article: Supplementary Figure 2 from Targeting eNOS in Pancreatic Cancer
Supplementary Figure 2 from Targeting eNOS in Pancreatic Cancer Open
PDF file - 243K, Tumorigenic growth of human pancreatic cancer cell lines treated with L-NAME
View article: Data from Targeting eNOS in Pancreatic Cancer
Data from Targeting eNOS in Pancreatic Cancer Open
Mortality from pancreatic ductal adenocarcinoma cancer (PDAC) is among the highest of any cancer and frontline therapy has changed little in years. Activation of endothelial nitric oxide synthase (eNOS, NOS3, or NOS III) has been implicate…
View article: Supplementary Figure 3 from Targeting eNOS in Pancreatic Cancer
Supplementary Figure 3 from Targeting eNOS in Pancreatic Cancer Open
PDF file - 164K, L-NAME has minimal effects on cellular proliferation in vitro
View article: Supplementary Figure Legends 1-3 from Targeting eNOS in Pancreatic Cancer
Supplementary Figure Legends 1-3 from Targeting eNOS in Pancreatic Cancer Open
PDF file - 57K
View article: Supplementary Figure 1 from Targeting eNOS in Pancreatic Cancer
Supplementary Figure 1 from Targeting eNOS in Pancreatic Cancer Open
PDF file - 243K, eNOS is upregulated in human pancreatic cancers
View article: Supplementary Figure 1 from Targeting eNOS in Pancreatic Cancer
Supplementary Figure 1 from Targeting eNOS in Pancreatic Cancer Open
PDF file - 243K, eNOS is upregulated in human pancreatic cancers
View article: Supplementary Figure 2 from Targeting eNOS in Pancreatic Cancer
Supplementary Figure 2 from Targeting eNOS in Pancreatic Cancer Open
PDF file - 243K, Tumorigenic growth of human pancreatic cancer cell lines treated with L-NAME
View article: Data from Targeting eNOS in Pancreatic Cancer
Data from Targeting eNOS in Pancreatic Cancer Open
Mortality from pancreatic ductal adenocarcinoma cancer (PDAC) is among the highest of any cancer and frontline therapy has changed little in years. Activation of endothelial nitric oxide synthase (eNOS, NOS3, or NOS III) has been implicate…
View article: Supplementary Figure 3 from Targeting eNOS in Pancreatic Cancer
Supplementary Figure 3 from Targeting eNOS in Pancreatic Cancer Open
PDF file - 164K, L-NAME has minimal effects on cellular proliferation in vitro
View article: Supplementary Figure Legends 1-3 from Targeting eNOS in Pancreatic Cancer
Supplementary Figure Legends 1-3 from Targeting eNOS in Pancreatic Cancer Open
PDF file - 57K
View article: Activating PIK3CA Mutations Induce an Epidermal Growth Factor Receptor (EGFR)/Extracellular Signal-regulated Kinase (ERK) Paracrine Signaling Axis in Basal-like Breast Cancer
Activating PIK3CA Mutations Induce an Epidermal Growth Factor Receptor (EGFR)/Extracellular Signal-regulated Kinase (ERK) Paracrine Signaling Axis in Basal-like Breast Cancer Open
Mutations in PIK3CA, the gene encoding the p110α catalytic subunit of phosphoinositide 3-kinase (PI3K) have been shown to transform human mammary epithelial cells (MECs). These mutations are present in all breast cancer subtypes, including…
View article: Efferocytosis produces a prometastatic landscape during postpartum mammary gland involution
Efferocytosis produces a prometastatic landscape during postpartum mammary gland involution Open
Breast cancers that occur in women 2–5 years postpartum are more frequently diagnosed at metastatic stages and correlate with poorer outcomes compared with breast cancers diagnosed in young, premenopausal women. The molecular mechanisms un…
View article: ErbB3 downregulation enhances luminal breast tumor response to antiestrogens
ErbB3 downregulation enhances luminal breast tumor response to antiestrogens Open
Aberrant regulation of the erythroblastosis oncogene B (ErbB) family of receptor tyrosine kinases (RTKs) and their ligands is common in human cancers. ErbB3 is required in luminal mammary epithelial cells (MECs) for growth and survival. Si…